Market Tracker

11/21 4:57am ET

Mesoblast Ltd (NASDAQ:MESO)

5.05
Delayed Data
As of Nov 20
 +0.02 / +0.40%
Today’s Change
4.39
Today|||52-Week Range
12.50
-5.61%
Year-to-Date

Today’s Trading

Previous close5.03
Today’s open5.06
Day’s range5.04 - 5.32
Volume30,315
Average volume (3 months)34,242
Market cap$469.7M
Dividend yield--
Data as of 3:58pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)-1,605.50%
Earnings growth (this year)+7.78%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-95.31%
P/E ratioNM
Price/Sales326.56
Price/Book0.84

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp-0.05-0.28%
RTIXRTI Surgical Inc+0.15+3.23%
SIENSientra Inc-0.08-0.57%
OFIXOrthofix Internation...-0.08-0.15%
Data as of 4:02pm ET, 11/20/2017

Financials

Last reporting dateNovember 14, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$1.9M
Annual profit (last year)-$76.8M
Net profit margin-3,951.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts